➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Baxter
Colorcon
Johnson and Johnson
Boehringer Ingelheim

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

MEDROL Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Medrol, and what generic alternatives are available?

Medrol is a drug marketed by Pharmacia And Upjohn and is included in three NDAs.

The generic ingredient in MEDROL is methylprednisolone. There are forty drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the methylprednisolone profile page.

US ANDA Litigation and Generic Entry Outlook for Medrol

A generic version of MEDROL was approved as methylprednisolone by WATSON LABS on October 16th, 1997.

  Start Trial

Drug patent expirations by year for MEDROL
Drug Prices for MEDROL

See drug prices for MEDROL

Drug Sales Revenue Trends for MEDROL

See drug sales revenues for MEDROL

Recent Clinical Trials for MEDROL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Uppsala UniversityPhase 2
Uppsala University HospitalPhase 2
National Cancer Institute (NCI)Phase 2

See all MEDROL clinical trials

Pharmacology for MEDROL

US Patents and Regulatory Information for MEDROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn MEDROL methylprednisolone acetate ENEMA;RECTAL 018102-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn MEDROL methylprednisolone TABLET;ORAL 011153-006 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn MEDROL methylprednisolone TABLET;ORAL 011153-004 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn MEDROL ACETATE methylprednisolone acetate OINTMENT;TOPICAL 012421-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Baxter
Colorcon
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.